Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00392873
Other study ID # 15353
Secondary ID
Status Completed
Phase N/A
First received October 25, 2006
Last updated May 3, 2017
Start date September 2006
Est. completion date December 2014

Study information

Verified date May 2017
Source Penn State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to examine the effects of increased food intake on the menstrual cycle and bone health in physically active women who have irregular or absent menstrual cycles. This study will examine whether a 12 month period of increased food intake will cause menstrual cycles to resume and help bones get stronger.


Description:

Low levels of estrogen found in physically active, premenopausal women with irregular or absent menstrual periods is likely caused by insufficient energy (calorie) intake compared to energy expenditure. Premenopausal women with menstrual disturbances and amenorrhea suffer from reductions in bone mineral density, particularly in the lumbar spine. Bone loss observed in amenorrheic women may be serious enough to result in osteoporotic fractures, but is also associated with a high prevalence of stress fractures. Increased calorie intake should help improve energy status, menstrual status, and bone health.

Comparison: Premenopausal women with irregular or absent menstrual periods will be assigned to either receive additional calories or serve as controls. A group of premenopausal women with normal menstrual periods will also be used for comparison.


Recruitment information / eligibility

Status Completed
Enrollment 233
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria for Ovulatory Control Volunteers:

- 18-35 years

- BMI 16-25 kg/m2

- At least 2 hr/wk of aerobic exercise

- Gynecological age >/= 5 years

- Weight stable (+/- 2 kg) last 6 months

- History of regular menses for 6 months

Inclusion Criteria for Women with Irregular or Absent Menses:

- 18-35 years

- BMI 16-25 kg/m2

- At least 3 hr/wk of aerobic exercise

- Gynecological age >/= 5 years

- Weight stable (+/- 2 kg) last 6 months

- No menses within past 3 months or 6 or less menses in last 12 months

- Low to normal bone mass (L1-L4 Z score </=0)

Exclusion Criteria for all participants:

- Hormonal contraceptives in last 6 months

- Smoking currently

- Current clinical diagnosis of an eating disorder

- Use of medications incompatible with measurement of reproductive or metabolic hormones, including thyroid medications that may interfere with any of the study outcomes.

- Dietary habits incompatible with prescribed diet for study

- Any metabolic, reproductive or bone disease

- Sedentary individuals with less than 120 minutes (2 hrs) of activity per week

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
EAMD+Calories
During the 12 month intervention, volunteers in the Increased calorie intake group will follow a modified dietary plan designed to achieve and maintain a target level of 20-30% above their previously determined baseline, in an effort to achieve a chronic energy surplus of +20-30% over their baseline energy requirements.

Locations

Country Name City State
United States Women's Health and Exercise Laboratories, The Pennsylvania State University University Park Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
Penn State University United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reproductive hormones 1 year
Primary Metabolic hormones 1 year
Primary Metabolic bone markers 1 year
Primary Bone mineral density 1 year
Secondary Eating Disorder Inventory-2 (EDI-2) 1 year
Secondary Three Factor Eating Questionnaire 1 year
See also
  Status Clinical Trial Phase
Completed NCT05688995 - COVID-19 Vaccines and the Menstrual Cycle
Completed NCT01927471 - Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
Completed NCT05083065 - Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
Recruiting NCT04940013 - Missed Period Pill Study Phase 4
Completed NCT03547453 - Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
Completed NCT04985591 - The Effect of Liposuction on Menses: a Retrospective Study Early Phase 1
Completed NCT06339476 - Exploring the Complex Links Between Menstrual Irregularity and Cellular Markers N/A
Completed NCT04006171 - Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women N/A
Completed NCT01555190 - Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone N/A
Active, not recruiting NCT05230316 - Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
Completed NCT05410314 - Nutritional Supplement Based on Myo-inositol-D-chiro-inositoln in Long-term Survivors of Lymphoma
Withdrawn NCT05518006 - An Investigation of Premama Balance and Its Effects on Hormonal Imbalances N/A
Not yet recruiting NCT05224726 - Platelet Rich Plasma for Uterine Scar N/A
Completed NCT04413058 - Menstrual Cycle Characteristics of Healthcare Professionals
Recruiting NCT05197491 - Women's Menstruation During the Covid-19 Pandemic